Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS) [Phase 2]
Phase 2 clinical trial update reporting results for the combination of decitabine and gemtuzumab ozogamicin in acute myeloid leukemia and hi…
-
CLINICAL_TRIALS trial_result · 2013-07-29Clinical Trial Update: A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome
A clinical trial evaluating Dacogen (decitabine) in patients with myelodysplastic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies [Phase 1]
Phase 1 pilot study evaluating haploidentical natural killer cell infusions for poor-prognosis non-AML hematologic malignancies has complete…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML [Phase 2]
A Phase 2 clinical trial evaluating high-dose cytarabine and mitoxantrone followed by autologous transplantation for therapy-related myelody…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Phase 1]
This Phase 1 dose-ranging trial evaluated Telintra in combination with Revlimid in patients with non-deletion (5q) low- to intermediate-1 ri…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients
A clinical trial evaluating a new reduced-intensity conditioning regimen of busulfan/fludarabine in older and/or intolerant patients with le…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated deferoxamine to manage iron overload before allogeneic stem cell transplantation in patients with acute myeloi…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies [Phase 3]
Phase 3 study evaluating methotrexate or pentostatin for graft-versus-host disease prophylaxis in risk-adapted allogeneic bone marrow transp…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation [Phase 4]
A Phase 4 clinical trial is evaluating decitabine given before allogeneic hematopoietic cell transplantation in patients with higher-risk my…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating decitabine in combination with gemtuzumab ozogamicin in adults with acute myeloid leukemia or high-risk myelodyspla…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating thymoglobulin in combination with cyclosporine in patients with aplastic anemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Observational Study of Iron Overload in Stem Cell Transplantation
This clinical trial update notes the completion of an observational study on iron overload in stem cell transplantation involving patients w…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Collection and Banking of Leukemia Cells MDS/AML [NA]
A completed clinical trial focusing on the collection and banking of leukemia cells in patients with myelodysplastic syndrome and acute myel…
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating a combination of decitabine, arsenic trioxide, and ascorbic acid for myelodysplastic syndrome has completed with re…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [Phase 1, Phase 2]
This clinical trial update reports on a completed Phase 1/2 study of liposomal daunorubicin combined with SU5416 for hematologic cancers tha…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Bendamustine in Acute Leukemia and MDS [Phase 1, Phase 2]
Phase 1/2 trial of bendamustine in acute leukemia and myelodysplastic syndromes was terminated with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase II clinical trial evaluating arsenic trioxide (Trisenox) in patients with myelodysplastic syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial update assessing the safety and efficacy of azacitidine in combination with lenalidomide in patients with higher-risk…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain [Phase 3]
Phase 3 clinical trial evaluating an opioid titration order sheet versus standard care for cancer-related pain; the study is completed with …
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies [Phase 2]
Phase 2 hematopoietic cell transplantation trial in pediatric patients with hematologic malignancies has completed and results have been pos…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Effectiveness of Protected Environment Rooms for AML and MDS
Clinical trial update on the effectiveness of protected environment rooms for Acute Myeloid Leukemia and Myelodysplastic Syndrome; the study…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients
This update reports a completed clinical trial studying symptom-related cytokines in patients with acute myeloid leukemia and myelodysplasti…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) [Phase 1]
This report notes the completion of a Phase 1 clinical trial evaluating azacitidine as maintenance therapy after allogeneic bone marrow tran…